120 likes | 397 Views
Natural Latex Medical Device Regulation. Mel E. Stratmeyer, Ph.D. Center for Devices and Radiological Health Food and Drug Administration. CDRH MISSSION. Insure Safety Effectiveness. CDRH ACTIONS. Problem Identification Advisory Role Research Regulatory Initiatives.
E N D
Natural Latex Medical Device Regulation Mel E. Stratmeyer, Ph.D. Center for Devices and Radiological Health Food and Drug Administration
CDRH MISSSION • Insure • Safety • Effectiveness
CDRH ACTIONS • Problem Identification • Advisory Role • Research • Regulatory Initiatives
PROBLEM IDENTIFICATION • Adverse event reporting system • High-risk groups
HIGH-RISK GROUPS • Pediatric spina bifida population 20%-60% • Healthcare workers 6%-10% • Rubber industry workers 6%
ADVISORY ROLE • Medical Alert • Industry cooperation • International Latex Conference • Standards development
RESEARCH • Allergen identification • Selection of reference allergen • Methods development • Refinement
REGULATORY INITIATIVES • Protein content guidance • Labeling regulation • Glove reclassification regulation
MEDICAL GLOVES : PROPOSED RULE • Reclassify from Class I to Class II • Special Controls • Label caution statements that include recommended limits • Label protein levels on NRL gloves • Label powder levels on all gloves • Expiration labeling
OTHER GOVERNMENT AGENCIES • OSHA Technical Information Bulletin-select “lower protein content”…”powder free…benefit…reducing systemic allergic responses’ • NIOSH Safety Alert-”powder-free with reduced protein content”
GOALS • Prevent • Sensitization • Adverse reactions